Anxiety

Where the papers sit

23 papers from the last 6 months study anxiety directly · updated from PubMed 1 Oct 2026

• Anxiety and Depression Care

  Anxiety and depression are being moved toward routine measurement and scalable support across medical and community settings. PHQ and GAD-7 scores anchor prevalence and symptom assessment, while AI conversational agents, mental-health apps, and EHR models test digital detection or intervention. Clinical studies add symptom mediation, perioperative anxiety reduction, stigma prediction, and a mechanistic herbal treatment, so endpoints remain diverse. Validation, engagement, and effectiveness across conditions remain unresolved.

  8 papers · 34.8%

• Resilience in Psychological Distress

  Psychological resilience and social support are emerging as modifiable buffers against anxiety and depression in caregivers and colorectal cancer patients. Rumination, maladaptive coping, attention to threat, insomnia, and sensory complaints recur as candidate pathways or clinical burdens. Parkinson's disease and frozen shoulder work broadens the question to non-pharmacological rehabilitation, while tinnitus studies emphasize assessment. The field remains focused on identifying protective factors and matching behavioral support to comorbidity rather than a single treatment.

  5 papers · 21.7%

• Behavioral Mental Health Support

  Yoga and laughter-based programs are being tested as low-burden ways to reduce anxiety, depression, and stress while supporting quality of life. Early work emphasizes feasibility and adjunctive use, including heart rate and heart rate variability in police officers and medication adherence in people with HIV. Autism-focused delivery also targets parenting stress, whereas youth work examines trust in risk prediction and preventive tools. Evidence remains preliminary and heterogeneous, with acceptability and physiological response still open.

  3 papers · 13%

• Others — Symptoms and Quality of Life

  Sleep, pain, mobility, and emotional symptoms are repeatedly linked to quality of life across cancer, dialysis, HIV, fibromyalgia, and chronic pain settings. Interventions range from medicinal cannabis and aromatherapy to virtual reality, while wearables and EEG seek objective markers of risk or symptom burden. Outcomes remain context-specific, spanning readmission, mortality, sleep, mood, and work ability rather than one shared endpoint. The cluster is therefore unified by patient-reported burden and function, not a single disease or treatment strategy.

  7 papers · 30.4%